Participare la conversatie/Discurs oral

Exprimare scrisa

• capacitate de utilizare a sistemelor Microsoft Windows
• buna cunoastere a instrumentelor Microsoft Office (Word, Excel, PowerPoint, Access)
• cunostinte elementare de grafica pe calculator
• utilizare internet pentru accesare baze de date, email, browsing

• Domeniu: nefrologie, medicina interna in numar de 390
• Indice Hirsch - 8
• Standarde minimale academice: p=7,4; i=2,1

• 2013 - Membru in Comisia de Evaluare si Asigurare a Calitatii Educationale din UMF  „Victor Babes” Timisoara, Facultatea de Medicina (HotarareaConsiliului Facultatii  Nr: 2/13642 din 30.10 2013
• 2013 - Membru in Comisia de Nefrologie a Ministerului Sanatatii (Ord. MS. Nr. 398/21.03.2013)
• 2013 - 2017 - Membru in Comitetul Director al Societatii Romane de Nefrologie

• 1991 - Membru Societatea Romana de Nefrologie
• 1992 - Membru al Asociatiei Timisoara Medicala
• 1995 - Membru al European Dialysis and Transplant Association (ERA- EDTA)
• 1995 - Membru al International Society of Nephrology (ISN)
• 2006 - Membru al Societatii Romane de Ultrasonografie in Medicina si Biologie (SRUMB), membru afiliat al Federatiei Europene ale Societatilor de Ultrasonografie in Medicina si Biologie (EFSUMB), membru afiliat al Federatiei Mondiale de Ultrasonografie in Medicina si Biologie (WFUMB)
• 2009 - Membru Societatea Romana de Imunologie
• 2011 - Membru Fundatia Acad. Marin Voiculescu;
• 2013 - Membru fondator Asociatia pentru Studii Reno-Metabolice si Nutritionale

• 2006- prezent-Editor regional “Revista Romana de Nefrologie”
• 2009 - 2013-Membru in Editorial Board of Nephrology Reviews - Open Access, peer-reviewed journal published online by PAGEPress, Pavia, Italy on behalf of Wichtig Editore, Milan, Italy;
• 2010- prezent- Editor, sectiunea nefrologie - Central European Journal of Medicine (cotatie ISI; ISSN: 1895-1058)
• 2015- Editor- International Journal of Diabetes and Clinical Research  (ISSN: 2377-3634)

• 2005 - 2006 - Reviewer „Timisoara Medical Journal”;
• 2007 - prezent - Reviewer „International Urology and Nephrology”; (cotatie ISI; ISSN: 0301-1623)
• 2007 - 2008 - Reviewer „Stroke”;
• 2008 - prezent - Reviewer „Nephrology” (revista AsiaPacific Society of Nephrology cotatie ISI; ISSN: 1440-1797);
• 2011 - prezent - Reviewer „Cardiovascular Diabetology”;( cotatie ISI; ISSN: 1475-2840)
• 2012 - prezent - Reviewer KDIGO Guidelines; ‚’’Kidney International’’;( cotatie ISI; ISSN: 0085-2538)
• 2013 - prezent - Reviewer “Diabetes Research and Clinical Practice”; (cotatie ISI; ISSN: 0168-8227)
• 2015 - Reviewer - „Anatolian Journal of Cardiology” (cotatie ISI; ISSN: ISSN 2149-2263)
• 2015 - Reviewer - „Biomarkers” (cotatie ISI; ISSN: 1354-750X )
• 2015 - Reviewer - „Journal of Cell Physiology” (cotatie ISI; ISSN: 1097-4652)
• 2015 - Reviewer - „Medical Ultrasound” (cotatie ISI; ISSN: 1844-4172)
• 2015 - Reviewer - „Proteome Science” (cotatie ISI; ISSN: 1477-5956 )

• 1995 - Cambridge First Cerificate in English;
• 1996 - Cambridge Certificate in Advanced English;
• 1998 - Cambridge Certificate of Proficiency in English;
• 2011 - Diploma Europeana de Limba Franceza nivel B2 (DELF-B2).

• 2014 - Premiul ‘Gh. Marinescu’ al Academiei Romane, Sectia de Stiinte Medicale, pentru cartea ‘Kidney and Brain’- a common pathophysiology, a shared fate, editura Lambert Academic Publishing, Saarbruecken, Germany, 2012

• 2002 - Phase IV Study-protocol P-03489 (Schering-Plough): A multicentric, Open-label Study investigating the efficacy and safety of Cedax (ceftibuten) in respiratory tract infections and urinary tract infections in adults and children (investigator);
• 2005 - Phase III Study-protocol 20010184 (Amgen): Trial to Reduce Cardiovascular Events with AranespR Therapy (TREAT) (investigator);
• 2008 - (AFFYMAX)AFX 01-13/2007: Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study of the Safety and Efficacy of AF37702 Injection for the Correction of Anemia in Patients with Chronic Renal Failure(CRF) not on Dialysis and not on Erythropoiesis Stimulating Agents(ESA) Treatment (investigator);
• 2008 - Phase III Study-protocol 2007-22-INJ-17: HX02-Hexal Randomized, Active-controlled, Open-label, Multicenter Study of the Safety and Efficacy of Erythropoietin Alpha   Injection for the Correction of Anemia in Patients with Chronic Renal Failure(CRF) not on Dialysis (investigator principal);
• 2009 - Phase III Study (Amgen): Correction of Anemia in Patients with Chronic Renal Failure (CRF) not on Dialysis and not on Erythropoiesis Stimulating Agents (ESA) Treatment (investigator);
• 2010 - Phase III Study (Ferrinject): Correction of Anemia in Patients with Chronic Renal Failure (CRF) not on Dialysis and not on Erythropoiesis Stimulating Agents (ESA) Treatment (investigator);
• 2011 - Phase II Study: A phase 2, multicenter, randomized, double blind, placebo-controlled study of the safety, clinical activity and pharmacokinetics of Bosutinib (PF-05208763) versus placebo in subjects with autosomal dominant polycystic kidney disease (ADPKD), protocol nr. B1871019 (3160A7-2211) (investigator principal - in derulare);
• 2011 - Phase III Study HX575-308: Open label, single arm, multicenter study to evaluate the safety and immunogenicity of HX575 epoetin alfa in the treatment of anemia associated with chronic kidney disease in pre-dialysis and dialysis patients (investigator principal - in derulare);
• 2011 - Phase IV Study: Evaluation of the treatment with Zemplar in the Therapy of Secondary Hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD) Stage 3 or 4 in the Conditions of Routine Clinical Practice. A Multi-Country Multi-Center Post-Marketing Observational Study in Routine Clinical Use in Eastern European Countries (investigator principal)
• 2013- A Phase II, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study to evaluate the efficacy and safety of once-daily administration of a chemokine CCR2/5 receptor antagonist (PF-04634817) in adults with type 2 diabetes and overt nephropathy(investigator)
• 2014- Phase III Study: A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Type 2 Diabetic Subjects with Nephropathy (Protocole No M11-352) (investigator principal- in derulare)
• 2014- Phase III Study: A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter  Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subjects With Type 2 Diabetes Mellitus and Diabetic Nephropathy (EUDRACT number: 2013-004494-28) (investigator principal- in derulare)
• 2015- A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Roxadustat for the treatment of Anemia in Chronic Kidney Disease Patients not on Dialysis (Protocol No-D5740C00001) (principal investigator - ongoing)

• 2011 - „Cercetare sociala” cod CPV 79315000-5 din cadrul subproiectului Technology Cares, finantat prin proiectul PEOPLE, Programul de Cooperare Internationala INTERREG IV C, 2011, membru in echipa de cercetare a unui proiect finantat cu un buget peste 10.000 EUR;  Proiectul a fost intitulat ‘Diagnosticul si recuperarea pacientilor afazici cu limba materna limba romana, consecutiv accidentelor vasculare cerebrale ischemice’ (noiembrie 2010-aprilie 2011);
• 2013 - ”Twinning Project for the Joint Development of the Research Infrastructure” – acronim HURO-  TWIN castigat de catre Universitatea din Szeged in parteneriat cu Universitatea de Medicina si Farmacie «Victor Babes» Timisoara in cadrul Programului de Cooperare Transfrontaliera Ungaria-Romania 2007-2013, in cadrul competitiei HU-RO 1101, axa prioritara 2 “Intarirea coeziunii sociale si economice in regiunea de granita”, domeniul major de interventie 2.2 “Promovarea cooperarii in domeniul C&D si inovarii”, actiunea 2.2.1 “Dezvoltarea infrastructurii comune de cercetare”, cod HURO/1101/086, perioada de derulare 01.01.2013 – 30.04.2014

1. 1995 - CME Course, World Congress of Nephrology, Madrid, Spain
2. 1997 - CME Course, World Congress of Nephrology, Sydney, Australia
3. 2002 - International Educational Course, Sinaia, Romania
4. 2003 - CME Course, World Congress of Nephrology, ERA-EDTA Congress, Berlin, Germany
5. 2006 - 4th Renal Failure Academy, Sinaia, Romania
6. 2007 - 5th Renal Failure Academy, Mamaia-Constanta, Romania
7. 2008 - 6th Renal Failure Academy, Venus, Romania (speaker)
8. 2009 - 7th Renal Failure Academy, Timisoara, Romania
9. 2011 - EBAC Accredited Educational Programme, Madrid, Spain
10. 2013-  Expert Exchange Forum-Abbvie-Madrid, Spain ( invited speaker)
11. 2014-  Expert Exchange Forum Elastography in Medicine, Timisoara, Romania

1. 1995 - World Congress of Nephrology, Madrid, Spain;
2. 1997 - World Congress of Nephrology, Sydney, Australia;
3. 2000 - ERA-EDTA Congress, Nice, France;
4. 2001 - World Congress of Nephrology, ASN Renal Week, San Francisco, USA;
5. 2003 - World Congress of Nephrology, ERA-EDTA Congress, Berlin, Germany
6. 2005 - World Congress of Nephrology, Singapore;
7. 2006 - World Joint Congress on Stroke, Cape Town, South Africa
8. 2007 - World Congress of Nephrology, Rio de Janeiro, Brazil;
9. 2008 - XXth Congress of European Federation of Societies for Ultrasound in Medicine and Biology, in conjunction with XIth Romanian Conference of Ultrasound in Medicine and Biology, Timisoara
10. 2009 - World Congress of Nephrology, Milan, Italy
11. 2009 - World Congress of Neurology, Bangkok, Thailand
12. 2010 - ERA-EDTA Congress, Munich, Germany
13. 2010 - 7th Transplant Symposium, Vienna, Austria
14. 2011 - ERA-EDTA Congress, Prague, Czech Republic
15. 2012 - ERA-EDTA Congress, Paris, France
16. 2013 - World Congress of Nephrology, Hong Kong, PR China
17. 2014-  ERA-EDTA Congress, Amsterdam, The Netherlands

• 1993 - Primul Congres National de Nefrologie, Bucuresti;
• 1997 - Al-II-lea Congres National de Nefrologie, Iasi;
• 2003 - Al-III-lea Congres National de Nefrologie, Cluj-Napoca;
• 2005 - Al-IV-lea Congres National de Nefrologie, Craiova;
• 2007 - Al-V-lea Congres National de Nefrologie, Poiana Brasov;
• 2009 - Al-V-lea Congres National de Nefrologie, Dializa, Transplant si Acces Vascular, Bucuresti;
• 2009 - Al-VI-lea Congres National de Nefrologie, Sinaia;
• 2010 - Al-VI-lea Congres National de Nefrologie, Dializa, Transplant si Acces Vascular, Bucuresti;
• 2011 - Conferinta ‘TimMedica’, Timisoara;
• 2011 - Conferinta Nationala NefroCarDia, Timisoara;
• 2011 - Al-VII-lea Congres National de Nefrologie, Timisoara;
• 2011 - Al-VII-lea Congres National de Nefrologie, Dializa, Transplant si Acces Vascular, Bucuresti;
• 2012 - Al-VIII-lea Congres National de Nefrologie, Dializa, Transplant si Acces Vascular, Bucuresti;
• 2012 - A-XV-a Conferinta Nationala de Stroke (AVC) cu participare internationala, Bucuresti;
• 2013 - Al-IX-lea Congres National de Nefrologie, Dializa, Transplant si Acces Vascular, Bucuresti;
• 2013-   Al-VIII-lea Congres National de Nefrologie, Sibiu
• 2014 -  A-VII-a Conferinta Nationala de Ultrasonografie in Medicina si Biologie, Timisoara
• 2015-  Al-IX-lea Congres National de Nefrologie, Iasi